Dr. Adrian M. Leibovici, MD

Dr. Leibovici practices at Rochester General Hospital in Rochester, New York, part of Rochester Regional Health.

Dr. Leibovici's NPI, 1437195344, was assigned on June 20, 2006. Dr. Leibovici graduated from Carol Davila University of Medicine and Pharmacy in 1980. Dr. Leibovici holds New York license 166339.

Dr. Leibovici's primary practice is Rochester General Hospital, at 1425 Portland Avenue, Rochester, NY 14621 in Monroe County. The practice phone is (585) 922-4000.

Dr. Leibovici's primary practice is Rochester General Hospital in Rochester, New York, part of Rochester Regional Health. Dr. Leibovici is also affiliated with Strong Memorial Hospital. The medical group on file is Rochester General Hospital. Dmand AI also links Dr. Leibovici to 7 more medical groups, 2 skilled nursing facilities and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Leibovici practices, 5 sites in all. Vendor and product names are available with a free account.

Psychiatry is Dr. Leibovici's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Leibovici is board certified in psychiatry by the American Board of Psychiatry and Neurology. Dr. Leibovici is licensed in New York.

Dmand AI lists depression among the conditions Dr. Leibovici treats.

CMS data shows 343 Medicare services from Dr. Leibovici across 3 procedure codes in 2022, for 12 Medicare patients. Medicare paid $10,329 for them.

CMS counts 12 Medicare patients who saw Dr. Leibovici in 2024. The largest group is 85 and over, with 0 patients. 75% of them have anxiety, and 75% have depression. Their average risk score is 1.31, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Leibovici's median patient age at 46, with 54% women.

In 2024, Dr. Leibovici wrote 64 Medicare Part D claims. 98% of them were for generic drugs. CMS names the drug for 34 of them, across 3 drugs with 11 or more claims each, at $463 in total drug cost. In 2023, CMS named 23 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Leibovici for performance year 2024, reported through an alternative payment model (APM). Dr. Leibovici accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 4 papers to Dr. Leibovici. The most frequent topics are Informed Consent, Mental Competency and Psychometrics. Dr. Leibovici's most frequent co-authors are Paul Stuart Appelbaum, MD, Glenn W. Currier, MD and Dilip V. Jeste, MD.

CMS Open Payments shows 9 general payments to Dr. Leibovici from 3 drug and device companies from 2017 to 2024. Food and beverage make up the largest share, 88% of the total. Janssen Pharmaceuticals, Inc paid the most, $141.

Dr. Leibovici graduated from Carol Davila University of Medicine and Pharmacy in 1980.

Dr. Leibovici is in network with 9 carriers, including Aetna, MVP Health Care and Highmark. PPO plans come from the most carriers, 7. Check the plan with the practice before a visit.